Navigation Links
BioInformatics, LLC New Market Report - Life Science Instruments: Maximizing Market Share
Date:6/17/2011

ARLINGTON, Va., June 17, 2011 /PRNewswire/ -- BioInformatics, LLC announces the upcoming release of their newest market report:  

Maximize Your Share of the Life Science Instrumentation Market (11-004)

Available at pre-release pricing until July 15, 2011

To help instrumentation suppliers maximize market share, BioInformatics LLC's upcoming market report benchmarks major suppliers and reveals scientists' preferences with regards to important brand attributes.  This primary research report will help suppliers with determining levels of satisfaction with multiple brands; quantifying brand differentiation, relevance and perceived quality; and establishing key purchasing factors.

This study analyzes similarities and differences between brands to identify degree of differentiation and brand awareness among major suppliers.  Additionally, twenty-two instrumentation suppliers will be profiled with regards to brand health; competitor differentiation; and brand strengths, weaknesses, opportunities & threats.

The following companies will be individually profiled in this report:

AB Sciex (Danaher)
Affymetrix
Agilent Technologies
Applied Biosystems (Life Technologies)
BD Biosciences
Beckman Coulter (Danaher)
Bio-Rad Laboratories
Bruker Daltonics
Caliper Life Sciences
EMD Millipore
GE Healthcare
Illumina
Molecular Devices (Danaher)
PerkinElmer Life and Analytical Sciences
Qiagen
Roche Applied Science (454 Life Sciences, Curagen)
Sequenom
Shimadzu Scientific Instruments
Takara Bio
Tecan
Thermo Scientific (Thermo Fisher Scientific)
Waters

"Instrument suppliers continually strive to differentiate their brands and engender customer loyalty," states Tamara Zemlo, Ph.D., MPH, Vice President of Advisory Services.  Dr. Zemlo adds: "To assist life science suppliers with brand positioning, in this report we've analyzed 22 major instrument suppliers with regards to key brand attributes."

To learn more about Maximize Your Share of the Life Science Instrumentation Market (11-004), a complimentary Executive Summary is available at:

Free Executive Summary

ABOUT BIOINFORMATICS, LLC

BioInformatics, LLC is the premier research and advisory firm serving the life science industry.  By leveraging our professional social network of more than 60,000 life scientists, we have supported more than 300 companies and provided insights that lead to better business decisions.  Our assignments include assessing the size and attractiveness of markets, optimizing product configurations and pricing, validating corporate acquisitions, measuring customer loyalty, and evaluating brand strength and positioning.

For more information contact:

Mary Follin
Manager, Marketing/Sales
BioInformatics, LLC
2111 Wilson Blvd., Suite 250
Arlington, VA  22201
703.778.3080 x13 (phone)
m.follin@gene2drug.com

http://www.gene2drug.com/


'/>"/>
SOURCE BioInformatics, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. BioInformatics, LLC New Report - Capitalizing on New Opportunities for Stem Cell Products, Now Available
2. BioInformatics, LLC New Report - The Market Outlook for Research Products in FY2010
3. BioInformatics, LLC New Market Reports - RNAi, Genomics and Membrane Protein Structure
4. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
5. FDA Advisory Committees Recommend Continued U.S. Marketing Authorization for Trasylol(R)
6. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
7. ADVENTRX Announces Completion of Patient Enrollment in ANX-530 Marketing-Enabling Clinical Study
8. Results of TRIUMPH-1 Trial of Viveta in Pulmonary Arterial Hypertension to Be Announced Before Market Open on Thursday, November 1, 2007
9. Inverness Medical Innovations to Present at CIBC World Markets 18th Annual Healthcare Conference on November 7, 2007
10. ADVENTRX Meets Primary Endpoint in ANX-530 Marketing-Enabling Clinical Study
11. Poniard Pharmaceuticals Provides Year-End Clinical Update at 2007 Lazard Capital Markets Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... SYDNEY , June 26, 2016 One of ... , has announced the formation of a new biotechnology company, Noxopharm ... raise $6m in an IPO and to list on the ASX. ... drug candidate, NOX66, ready to enter a Phase 1 clinical study ... been designed to address one of the biggest problems facing cancer ...
(Date:6/26/2016)... June 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as ... Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) ... Daylight Time). As previously announced on May ... definitive merger agreement under which Jazz Pharmaceuticals has commenced ...
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his ... David Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps ... in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set ... drug or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, ... traumatic event. , Trauma sufferers tend to feel a range of emotions, from depression, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, ... treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including robotic ... osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... proud to recognize Dr. Barry M. Weintraub as a prominent plastic surgeon and ... women in the world, and the most handsome men, look naturally attractive. Plastic ...
Breaking Medicine News(10 mins):